GeneDx Holdings (WGS) Reports Q4 results; offers guidance

GeneDx Holdings (NASDAQ: WGS) reported Q4 Revenue for the quarter at $95.3 million versus the consensus estimate of $61.7 million.

GUIDANCE:

GeneDx Holdings sees FY2025 revenue of $350-360 million, versus the consensus of $338.8 million.

For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• AI/ML Innovations plans $2M private placement on the CSE
• Phillips 66, Marathon Merger Talks Collapsed - Semafor